This is a highlights summary of an oral session given at the ENDO Online 2020 and presented by:

Elizabeth O. Buschur, MD
Ohio State University Wexner Medical Center, Columbus, OH, USA

The content is produced by Infomedica, the official reporting partner of ENDO Online 2020. The summary text was drafted by Patrick Moore, PhD, and reviewed by Marco Gallo, MD, an independent external expert, and approved by Raghu Mirmira, MD, PhD, the scientific editor of the program.

The presenting authors of the original session had no part in the creation of this conference highlights summary.

In addition, an expert commentary on the topic has been provided by:

Emily K. Sims, MD, MS
Indiana University School of Medicine, Indianapolis, IN, United States

 

Emily K. Sims, MD, MS
Indiana University School of Medicine, Indianapolis, IN, United States

Emily K. Sims MD, MS is a physician scientist specializing in pediatric endocrinology, with a long-term goal of addressing clinically relevant problems in diabetes utilizing molecular discovery. Her research focus revolves around the investigation of molecular mechanisms contributing to β cell dysfunction and the development of diabetes, the identification and verification of circulating biomarkers of β cell dysfunction, and clinical studies identifying and targeting β cell dysfunction in T1D.  She hopes to ultimately utilize knowledge gained for development of biomarkers and β cell-targeted therapeutics that allow for a more tailored approach to treatment of patients with or at-risk for diabetes.